Ortho Clinical Diagnostics (OCDX) reported Q1 EPS of $0.23, $0.03 better than the analyst estimate of $0.20. Revenue for the quarter came in at $495 million versus the consensus estimate of $508.21 million.
Ortho Clinical Diagnostics (OCDX) reported Q1 EPS of $0.23, $0.03 better than the analyst estimate of $0.20. Revenue for the quarter came in at $495 million versus the consensus estimate of $508.21 million.